Close Menu
    Zukunftsforschung

    Laut einer neuen Umfrage haben die USA den Höhepunkt der Fettleibigkeit überschritten. Ist es der Ozempic-Effekt?


    Laut einer neuen Umfrage haben die USA den Höhepunkt der Fettleibigkeit überschritten. Ist es der Ozempic-Effekt?

    https://www.independent.co.uk/news/health/obesity-rates-us-ozempic-weight-loss-b2624064.html

    View 3 Comments

    3 Comments

    1. amuka on

      My prediction from a month ago.

      [https://www.reddit.com/r/Futurology/comments/1fglshc/comment/ln373s4](https://www.reddit.com/r/Futurology/comments/1fglshc/comment/ln373s4)

      —

      The end of the obesity epidemic. Due to advances in GLP-1-like drugs, the obesity ratio in the US will be under 15% by 2040

      **2023-2024 (Obesity Rate: ~42%). We are here**

      * Wider Use of Semaglutide (Ozempic/Wegovy)
      * Solve availability and shortage production issues
      * More healthcare providers adopt GLP-1

      **2025-2026 (Obesity Rate: ~39%)**

      * Approval for Pediatric Use
      * Expanded Insurance Coverage
      * Introduction of Oral GLP-1 Drugs

      **2027-2028 (Obesity Rate: ~35%)**

      * Digital Health Integration

      **2029-2030 (Obesity Rate: ~32%)**

      * Combination Therapies Introduced

      **2031-2032 (Obesity Rate: ~29%)**

      * Long-acting formulations (monthly doses)

      **2033-2040 (Obesity Rate: ~15%)**

      * GLP-1 therapies have become a mainstream component of obesity treatment protocols.
      * Preventive Use Exploration

      This might look small, but it has significant societal consequences, starting with a longer lifespan average.

    2. amuka on

      The U.S. obesity rate has peaked and declined by 2% between 2020 and 2023, according to a National Health and Nutrition Examination survey. The decrease was seen in both men and women, though severe obesity remained higher in women. Education level played a role, with lower rates in those holding bachelor’s degrees. Weight-loss drugs, like Wegovy and Ozempic, may be contributing to this decline, as more than 15 million Americans are using them. Obesity still affects 2 in 5 adults and 15 million children.

    3. Glaive13 on

      Yes, I imagine there would be a 600% increase in people taking a weight loss drug when it got rebranded as the best weight loss drug instead of a diabetes drug. Kind of wonder if this is an AI post of an AI article or just a random semaglutide ad.

    Leave A Reply